 Nimodipine resuscitation out-of-hospital ventricular fibrillation placebo-controlled double-blind randomized trial fifty-five consecutive patients out-of-hospital ventricular fibrillation physician-manned advanced life support unit nimodipine placebo dosage micrograms/kg intravenous injection restoration spontaneous circulation infusion micrograms/kg minute hours significant difference survival rate nimodipine-treated patients placebo-treated patients patients Recurrent ventricular fibrillation treatment patient nimodipine group patients placebo group post hoc analysis patients long delays advanced life support minutes survival rate nimodipine patients placebo patients Nimodipine benefit patients delayed resuscitation